The relationship between vitamin D deficiencies and life quality of FMS patients
The relationship between vitamin D deficiencies and life quality of FMS patients
Aim: Fibromyalgia syndrome (FMS) is a chronic musculoskeletal system disease characterized by widespread pain. Nonspecific skeletal pain can also be seen in patients with vitamin D deficiency. The association between low levels of vitamin D and non-specific musculoskeletal pain, including FMS, is controversial. The aim of this study is to assess the relationship between vitamin D deficiencies and disease activity, life quality of FMS patients.Materials and Methods: Patients with Fibromyalgia (FMS) classified according to American College of Rheumatology (ACR) criteria. 25-OH vitamin D levels below 20 ng/ml were accepted as vitamin D deficiency. Study groups classified as first group;patient with isolated FMS (n:36), second group; isolated vitamin D deficiency (n:41) and third group was FMS in together with vitamin D deficiency (n:70). Pain level was measured by the visual analog scale (VAS). Functional and life quality assessments were determined by using Short Form Heath Survey 36 (SF-36) and Fibromyalgia Impact Index (FIQ).Results: In isolated FMS group, vitamin D level was found higher than other two groups (p>0.05). At the assessment of quality of life, VAS and FIQ scores in FMS group were significantly higher than ones found in vitamin D deficiency group (p
___
- Armstrong DJ, Meenagh GK, Bickle I. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007;26(4):551-4.
- Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, Hahne J, Friedrich M. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain. 2014;155(2):261-8.
- Visser M, Deeg DJ, Lips P. Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766-72.
- Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxy vitamin D3 receptors and activities in muscle. J Biol Chem. 1985;260(15):8882-91.
- Sivas FA, Başkan BM, Aktekin LA, Çınar NK, Yurdakul FG, Ozoran K. Fibromiyalji hastalarında depresyon, uyku bozukluğu ve yaşam kalitesinin değerlendirilmesi. Turk J Phys Med Rehab. 2009;55(1):8-12.
- Marques AP, Ferreira EA, Matsutani LA, Pereira CA, Assumpção A. Quantifying pain threshold and quality of life of fibromyalgia patients. Clin Rheumatol. 2005;24(3):266- 71.
- Linares MCU, Perez IR, Perez MJB, Lima AOL, Torres EH, Castano JP. Analyses of the impact of fibromyalgia on quality of life: associated factors. Clin Rheumatol. 2008;27(5):613-9.
- Demiral Y, Ergor G, Unal B, Semin S, Akvardar Y, Kivircik B, et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health. 2006;6:247.
- Bhatty SA, Shaikh NA, Irfan M, Kashif SM, Vaswani AS, Sumbhai A, Gunpat J. Vitamin D deficiency in fibromyalgia. J Pak Med Assoc. 2010;60(11):949-51.
- Abokrysha NT. Vitamin D deficiency in women with fibromyalgia in Saudi Arabia. Pain Med. 2012;13(3):452-8.
- Tibebeselassie Seyoum Keflie M.Sc, Nils Nölle M.Sc, Christine Lambert Ph.D, Donatus Nohr Ph.D, Hans Konrad Biesalski Ph.D. M.D. Vitamin D deficiencies among tuberculosis patients in Africa: A systematic review. Nutrition. 2015;31:1204-12.
- Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12.
- Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009;36(6):1304-11.
- Bidari A, Hassanzadeh M, Mohabat MF, Talachian E, Khoei EM. Validation of a Persian version of the fibromyalgia impact questionnaire (FIQ-P). Rheumatol Int. 2014;34(2):181-189.
- Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, et all. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113-22.
- Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, et all. Vitamin D Levels in Women with Systemic Lupus Erythematosus and Fibromyalgia. J Rheumatol 2001;28(11):2535-9.
- Al-Jarallah K, Shehab D, Abraham M, Mojiminiyi OA, Abdella NA. Musculoskeletal pain: should physicians test for vitamin D level? Int J Rheum Dis 2013;16(2):193-7.
- Ulusoy H, Sarica N, Arslan S, Ozyurt H, Cetin I, Birgul Ozer E, et all. Serum vitamin D status and bone mineral density in fibromyalgia. Bratisl Lek Listy 2010;111(11):604-9.
- Okumus M, Koybası M, Tuncay F, Ceceli E, Ayhan F, Yorgancioglu R, et all. Fibromyalgia syndrome: is it related to vitamin D deficiency in premenopausal female patients? Pain Manag Nurs 2013;14(4):e156-63.
- Tandeter H, Grynbaum M, Zuili I, Shany S. Serum 25-OH vitamin D levels in patients with fibromyalgia. Isr Med Assoc J 2009;11(6):371-2.
- Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculo-skeletal pain. Mayo Clin Proc 2003;78(12):1463-70.
- Holick MF. Too little vitamin D in premenopausal women: why should we care? Am J Clin Nutr 2002;76(1):3-4.
- Zanni GR. Diagnosing and treating fibromyalgia. Consult Pharm 2009;24(8):572-8.
- The WHOQOL Group. The development of the WorldHealth Organisation quality of life assessment instrument (the WHOQOL). In: Orley J, Kuyken W, eds, Quality of Life Assessment: International Perspectives. Heidelberg: Springer Verlag 1994:41-57.
- Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK. Prevalence and clinical correlates of vitamin D inadequency among patients with chronic pain. Pain Med 2008;9(8):979-84.
- Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004;229(11):1136-42.
- Campos R, Vázquez M. Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated. Clin Rheumatol 2012;31(2):347-55.
- Al Allaf AW, Mole PA, Paterson CR, Pullar T. Bone health in patients with fibromyalgia. Rheumatology 2003;42(10):1202-6.
- Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol Suppl 2005;32(Suppl 75):6-21.
- Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et all. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012;2012:426130.